According to Invitae 's latest financial reports the company's current revenue (TTM) is $0.48 B. In 2022 the company made a revenue of $0.51 B an increase over the years 2021 revenue that were of $0.46 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.48 B | -6.72% |
2022 | $0.51 B | 12.13% |
2021 | $0.46 B | 64.68% |
2020 | $0.27 B | 28.95% |
2019 | $0.21 B | 46.8% |
2018 | $0.14 B | 116.5% |
2017 | $68.22 M | 172.36% |
2016 | $25.04 M | 198.97% |
2015 | $8.37 M | 422.32% |
2014 | $1.6 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Celldex Therapeutics CLDX | $6.88 M | -98.57% | ๐บ๐ธ USA |
HTG Molecular Diagnostics
HTGM | $6.21 M | -98.71% | ๐บ๐ธ USA |
CareDx CDNA | $0.28 B | -41.79% | ๐บ๐ธ USA |